ighriskofischaemicevents(e.g.elevatedcardiactroponins),regardlessofinitialtreatmentstrategyandincludingthosepretreatedwithclopidogrel(whichshouldbediscontinuedwhenticagrelorisstarted).IB普拉格雷(负荷剂量60mg,日剂量10mg):推荐用于无禁忌证**、准备接受PCI治疗者。Prasugrel(60mgloadingdose,10mgdailydose)mendedinpatientswhoareproceedingtoPCIifnocontraindication.IB氯吡格雷(负荷剂量300–600mg,日剂量75mg):推荐仅用于无法获得替格瑞洛或普拉格雷或需要口服抗凝药治疗的患者Clopidogrel(300–600mgloadingdose,75mgdailydose)mendedforpatientswhocannotreceiveticagrelororprasugrelorwhorequireoralanticoagulation.IB出血高风险者,药物洗脱支架(DES)置入术后,可考虑应用P2Y12受体抑制剂3-6个月治疗。P2Y12inhibitoradministrationforashorterdurationof3–6monthsafterDESimplantationmaybeconsideredinpatientsdeemedathighbleedingrisk.IIbA冠状动脉解剖情况未知的患者,不推荐应用普拉格雷。mendedtoadministerprasugrelinpatientsinwhomcoronaryanatomyisnotknown.IIIB
全文预览
